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Abstract
Background: The molecular mechanism that initiates the formation of the vertebrate central nervous system has
long been debated. Studies in Xenopus and mouse demonstrate that inhibition of BMP signaling is sufficient to
induce neural tissue in explants or ES cells respectively, whereas studies in chick argue that instructive FGF
signaling is also required for the expression of neural genes. Although additional signals may be involved in neural
induction and patterning, here we focus on the roles of BMP inhibition and FGF8a.
Results: To address the question of necessity and sufficiency of BMP inhibition and FGF signaling, we compared
the temporal expression of the five earliest genes expressed in the neuroectoderm and determined their
requirements for induction at the onset of neural plate formation in Xenopus. Our results demonstrate that the
onset and peak of expression of the genes vary and that they have different regulatory requirements and are
therefore unlikely to share a conserved neural induction regulatory module. Even though all require inhibition of
BMP for expression, some also require FGF signaling; expression of the early-onset pan-neural genes sox2 and
foxd5a requires FGF signaling while other early genes, sox3, geminin and zicr1 are induced by BMP inhibition alone.
Conclusions: We demonstrate that BMP inhibition and FGF signaling induce neural genes independently of each
other. Together our data indicate that although the spatiotemporal expression patterns of early neural genes are
similar, the mechanisms involved in their expression are distinct and there are different signaling requirements for
the expression of each gene.
Background
Development of the vertebrate central nervous system
(CNS) is initiated during gastrulation when dorsal ecto-
dermal cells are converted to the neural fate. There are
two prevailing models for the induction of the CNS.
T h ef i r s t ,t h en e u r a ld e f a u l tm o d e l ,a r o s ef r o me x p e r i -
ments demonstrating that in the absence of bone mor-
phogenetic protein (BMP) signaling, amphibian
ectodermal explants form neural tissue instead of epi-
dermis [1,2]. Formation of the nervous system by default
is highly conserved. In the protostome Drosophila mela-
nogaster, neural tissue forms as a result of inhibition of
the BMP homolog Decapentaplegic (Dpp) by the Chor-
din ortholog Sog [3]. Furthermore, the Xenopus BMP
antagonist Noggin is sufficient to inhibit Dpp and
induce neuroectoderm in fruit flies [4], and overexpres-
sion of Sog induces a secondary axis in Xenopus
embryos [5]. The second model, the instructive signaling
model, arose from studies of chick embryonic develop-
ment and indicated that inhibition of BMP signaling is
not sufficient to induce neural tissue, and that instruc-
tion from another signaling pathway such as FGF (fibro-
blast growth factor), is required. There is evidence
supporting both models in multiple vertebrates [6,7],
thus feeding the controversy over which signals are
necessary and sufficient during vertebrate CNS
induction.
Experiments in ES cells, mouse and zebrafish embryos
support the model that the vertebrate CNS is formed by
default. Like Xenopus ectodermal explants [8], mouse ES
cells [9], and human ES [10-12] and induced pluripotent
stem cells [11] are converted to rostral neural tissue
when BMP signaling is inhibited. In the mouse epiblast, * Correspondence: emc26@georgetown.edu
Department of Biology, Georgetown University, Washington DC, USA
Rogers et al. BMC Developmental Biology 2011, 11:74
http://www.biomedcentral.com/1471-213X/11/74
© 2011 Rogers et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.BMP2/4 signaling maintains pluripotency and prevents
the acquisition of a neural fate, whereas inhibition of
BMP signaling induces neural tissue independent of
FGF signaling [13]. Similarly, in zebrafish, BMP inhibi-
tion is sufficient for the induction of anterior neural
genes and FGF signaling is not required for induction
but rather for posteriorization of the induced tissue [14].
Although BMP inhibition clearly plays a role in neural
specification in many organisms, alone it does not effec-
tively induce neural tissue formation in Xenopus ventral
ectoderm [15-17] or outside of the chick dorsal ecto-
derm [18], which indicates that an instructive signal is
required. The leading candidate for this instructive sig-
nal is FGF. In both chick and frog, overexpression of
FGF2, FGF4, or FGF8 induces the expression of poster-
ior neural genes [18-21] and the activation of FGF sig-
naling in combination with BMP antagonism induces
the expression of pan-neural genes in non-neural ecto-
dermal territories [17,19]. Loss of function studies in
mESCs, chick and Xenopus embryos also suggest a role
for instructive signaling by FGF in neural induction. For
example, inhibition of FGF receptors or Erk1/2 by expo-
sure to pharmacological inhibitors eliminated differen-
tiation of mESCs into neurons [22] and resulted in a
loss of neural tissue in frog [15], zebrafish [23] and
chick [24]. Furthermore, overexpression of the dominant
negative FGF receptor 4a reduced the expression of the
neural progenitor marker, sox2, in tailbud-stage Xenopus
embryos [15] and the formation of neural tissue in ecto-
dermal explants in response to Noggin [25].
It has been difficult to dissect out an independent role
for FGF in neural induction because FGF signaling has
significant roles in mesodermal development [26] and
neural anterior-posterior patterning [27], induces neural
tissue via interference with BMP transcription and
transduction [26-28] and has been proposed to maintain
rather than induce a neural progenitor population
[29-32]. Specifically, studies suggest that neural specifi-
cation in response to FGF is not instructive or indepen-
dent from BMP inhibition but rather, is the result of
interference with BMP signaling via inhibition of Smad1
activity [28] or the transcription of BMP [29,30]. It has
also been proposed that FGF signaling is dispensable for
induction and instead is required for the maintenance of
neural progenitors. This is supported by studies in: (1)
Xenopus ectodermal explants in which sox2 and sox3
expression is not maintained when FGF signaling
through FGFR1 and 2 is inhibited [31]; (2) the mouse
olfactory bulb and retina in which a proliferating pro-
genitor population is decreased in the absence of FGF
signaling [32,33] and; (3) hESCs in which exogenous
FGF maintains cells in an undifferentiated state [34].
Furthermore, the approaches and techniques used to
investigate the role of FGF have been called to question.
It has been argued that incorrect markers were analyzed
at the wrong developmental stages and in the wrong tis-
sues, and that doses of pharmacological inhibitors were
lethal or detrimental to development [8]. With this con-
flicting data and the variables added by the use of many
different model organisms, stages, neural markers and
FGF inhibitors (small molecules, dominant negative
receptors, morpholinos), it remains unclear if FGF sig-
naling is required in addition to, or independent of,
BMP inhibition for the induction of neural genes.
This study compares the regulatory requirements for
the onset and maintenance of multiple early neural
genes in Xenopus embryos. Using multiple genes in one
organism has allowed us to determine whether FGF sig-
naling is required for the induction of multiple early
neural genes independent of BMP inhibition, and also to
determine the role of FGF8a in neural development.
Using gain and loss of function assays, we show that
sox2 and foxd5a require FGF signaling for neural induc-
tion and that sox3 and geminin require FGF signaling
for maintenance of expression. Ultimately, we show that
depending on the gene of interest, the ability of FGF to
induce expression can be dependent on the absence of
BMP signaling and may be indirect via the induction of
mesoderm.
Results
Response of early neural genes to BMP inhibition and
FGF signaling
The early neural genes sox2, sox3, geminin, foxD5a, soxD
and zicr1 are expressed broadly in the neuroectoderm at
the time of neural induction in response to neural indu-
cing signals [31,35-39]. We compared their expressions
at stage 8 (mid-blastula transition, 7+ hpf), through the
onset of gastrulation and neural induction (stage 10.5,
10 hpf) and in neurula embryos (stage 17, 24 hpf) (Fig-
ure 1A). The maternal genes, soxD, sox3 and geminin
are expressed strongly at 7 hpf whereas foxD5a, which is
also maternally expressed, is expressed at low levels at 7
hpf with levels increasing at 8 hpf and peaking at 10
hpf. The expression levels of the zygotically expressed
gene zicr1 are fairly constant whereas sox2 levels
increase from 7 to 24 hpf. Both FGF8 and the BMP
antagonist, noggin are expressed at 7 hpf preceding
neural induction. All of the genes are expressed prior to
the onset of gastrulation with zygotic FGF8 expressed
prior to foxd5a and sox2 expression indicating that it
may play a role in the induction of these two genes but
not the others.
To determine if the early neural genes respond to
BMP antagonism and/or FGF signaling, we overex-
pressed Noggin, FGF8a or a combination of both and
analyzed the expression of the early neural genes and
the proneural gene neurogenin (ngnr1). We used FGF8a
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Page 2 of 13Figure 1 Temporal expression of early neural genes and response to Noggin and FGF8a. Semi-quantitative RT-PCR of early neural genes
in embryos over time (A, B) or in ectodermal explants (C, D). Explants are from uninjected (UI) embryos or those injected with mRNA coding for
Noggin (Nog), FGF8a, or Nog + FGF8a. Embryos in (A) were collected at the times indicated at top (hours post fertilization = hpf) and explants
were collected at stage 11.5 (C) or 17 (D). Ef1a expression is a loading control. Samples without MMLV RTase added were used as RT- controls
(far right). (E) Immunohistochemistry for phosphorylated Histone H3 of ectodermal explants dissected from embryos injected with mRNA coding
for Nog, FGF8a, or Nog+ FGF8a and cultured to stage 17. Explants injected with Nog+ FGF8a are up to 1.7 fold (cm) bigger than those from
uninjected embryos. Graph is showing the number of cells marked with pH3 per mm
2 expression in n = 10 explants. Nog+ FGF8a caps have 1.8
fold more pH3 per count area than uninjected explants (p=.0001). UI indicates explants that were dissected from uninjected embryos, WE is
whole embryo.
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Page 3 of 13because its misexpression was reported to induce neural
tissue in explants without inducing mesoderm [21], and
because FGF8a overexpression does not induce Xbra
expression in whole embryos (Additional File 1, Fig.
S1A). Embryos were injected at the 1-cell stage, col-
lected at stage 10 and assayed by RT-PCR. Expression of
soxD, sox3, zicr1, foxd5a and ngnr1 was enhanced by
overexpression of Noggin or FGF (Figure 1B). However,
expression of gem and sox2 was unchanged (Figure 1B)
indicating that BMP antagonism and FGF8 are not suffi-
cient to enhance their expression at this stage.
To determine if FGF8a signaling is sufficient to acti-
vate or maintain the expression of the early neural
genes, we analyzed their expression in gastrula (st.
11.5) and neurula (st. 17) stage ectodermal explants
(Figure 1C and 1D) in response to Noggin, FGF8a
and Nog+FGF8a. Genes expressed at high maternal
levels (sox3, soxD and gem) were not examined at
stage 11.5. As shown in prior studies, BMP inhibition
induced the expression of neural progenitor markers
(sox2, sox3 and geminin) and the other early neural
markers, (s o x D ,z i c r 1 ,f o x d 5 a) by st. 17. At stage 11.5,
FGF8a induced zicr1, foxd5a and sox2 expression and
by stage 17 induced neuron formation; however, it
also induced the expression of the pan-mesodermal
marker xbra (Figure 1C, D) and the dorsal mesoderm
marker and BMP antagonist, noggin (Figure 1D).
Therefore, it is possible that FGF8a alters neural gene
expression indirectly via signals from the dorsal
mesoderm.
Explants from embryos co-injected with Noggin and
FGF8a are comprised of neural progenitors (sox2+, sox3
+a n dgem+) and neurons (n-tub+) (Figure 1D) and
have a distinct morphology; by stage 17, they are ~ 2-
fold larger than UI, Noggin or FGF8a caps indicating
either increased cell size or proliferation (Figure 1E). To
determine if the increase in explant size was due to
increased proliferation, we performed immunohisto-
chemistry to detect phosphorylated Histone H3 (Figure
1E), an indicator of mitosis. Explants from embryos
injected with Nog and FGF8a mRNA had an average of
1.8 fold more proliferating cells per square millimeter
than uninjected explants (Figure 1E, p = .0001, Student’s
T-Test, n = 10). To verify that the size difference was
not due to the presence of large migratory neural crest
cells with extended processes, we assayed for the expres-
sion of the neural crest marker, slug. These explants did
not express slug (data not shown), but did express the
epidermal and mesodermal marker vent2, the neuronal
marker n-tub and the proliferating progenitor markers
sox2, sox3 and gem (Figure 1D). One possible explana-
tion for the mixed cell population in these large explants
is that their fate varies with the level of Noggin or FGF
received.
Ectoderm is competent to respond to BMP inhibition and
FGF signaling prior to the onset of gastrulation
To determine when ectodermal cells are competent to
respond to FGF8a signaling or BMP inhibition by Nog-
gin, we assayed for the expression of the early neural
genes, zicr1, foxd5a and sox2 prior to MBT (6 hpf) and
until the onset of gastrulation and neural induction (10
hpf). Embryos were injected with mRNA coding for
Noggin, FGF8a or Noggin+ FGF8a in 1 of 2-cells and
collected at 6 hpf and every hour after until stage 10.5
(10 hpf). We performed whole-mount in situ hybridiza-
tion (WISH) and semi-quantitative RT-PCR to detect
the expression of zicr1, sox2 and foxd5a (Figure 2A-D),
which were expressed between 7 and 10 hpf (Figure 1A)
in embryos and induced by both Noggin and FGF8a by
stage 11.5 in ectodermal explants (Figure 1C). Endogen-
ous expression of zicr1 was first detected by WISH at 8
hpf (Figure 2A) and by RT-PCR at 7 hpf. BMP inhibi-
tion by Noggin enhanced expression of zicr1 at 8 hpf
(Figure 2A red arrows, Figure 2D) and by a truncated
BMPR (tBR) at 7 hpf (Additional File 2, Figure S2A, C).
FGF8a also increased zicr1 expression by 8-9 hpf (Figure
2 A ,D ,A d d i t i o n a lF i l e2 ,F i g u r eS 2 C ) .L o wl e v e l so f
zicr1 were detected at all stages tested, thus neither
BMP inhibition nor FGF signalling induced expression
prematurely. In contrast, foxd5a expression was induced
by Noggin and FGF8a by 8 and 7 hpf (Figure 2B red
arrows, 2D), respectively, whereas endogenous dorsal-
specific expression was first detected at 9 hpf. Sox2
expression was also induced prematurely at 8-9 hpf (Fig-
ure 2C, D), and expanded by FGF8a, Noggin and tBR at
10 hpf (stage 10.5) (Figure 2C, Additional File 2, Figure
S2B). In summary, foxd5a and zicr1 are induced and
expanded, respectively, in the ectoderm in response to
BMP inhibition and FGF8a signalling by 8 hpf, whereas
Sox2 expression is not significantly altered in response
to FGF8a signaling until much later after the onset of
endogenous expression (10 hpf). These experiments
indicate that early neural genes are induced by Noggin
by 8 hpf and respond to FGF8a at different times.
FGF signaling is required for the induction of sox2 and
foxd5a expression
In Xenopus, the induction of neural tissue occurs at the
onset of gastrulation in response to BMP inhibition, and
this induction may be dependent on instructive FGF sig-
naling. To determine if BMP inhibition and/or FGF sig-
naling are required for neural tissue formation, we
analyzed the expression of the early neural genes in
response to constitutively active BMP signaling and the
loss of FGF signaling. In support of the neural default
model, overexpression of a constitutively active BMP
receptor (Alk3) inhibited the expression of the six early
neural genes at the onset of neural induction
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Page 4 of 13(Additional File 3, Fig. S3) and Noggin expanded their
expression (Figure 3A-D and data not shown), suggest-
ing that the expression of all early neural genes requires
BMP inhibition. In contrast, each of the early neural
genes responded differently to loss of FGF signaling. To
interfere with FGF signaling, we used dominant negative
FGFR4a (Δ4a) because it is the receptor through which
FGF8 stimulates neuron formation [40] and was deemed
more effective at blocking neural development than
dominant negative FGFR1 (XFD) [25,41]. Surprisingly,
although FGF8a induced soxD expression in explants,
Δ4a overexpression had no effect on soxD expression in
embryos (data not shown). However, Δ4a expression
inhibited sox2 (n = 42/62) and foxd5a (n = 23/25)
expression and reduced zicr1 expression (n = 20/30) at
stage 10.5, and sox3 and gem expression (sox3,n=5 6 /
63 and gem 12/12) at stage 12 (Figure 3A-D). Since FGF
signaling inhibits BMP signaling via phosphorylation of
Smad1 [28], we wanted to determine if the Δ4a pheno-
types could be rescued by Noggin, or in other words,
were due to increased BMP signaling. Zicr1, sox3 and
gem expression were rescued by overexpression of Nog-
gin (Figure 3B, n = 26/26, 3D, n = 17/21, n = 15/20)
and therefore not dependent on FGF signaling. How-
ever, sox2 and foxd5a expression were not rescued by
overexpression of Noggin (Figure 3A, C) indicating an
independent role for FGF signaling. These data indicate
that FGF signaling is required for the expression of sox2
and foxd5a.
We next tested whether FGF signaling through FGFR4a
is required for the expression of early neural genes in
explants in which BMP signaling is inhibited. We over-
expressed Δ4a in ectodermal explants neuralized by
Noggin and performed semi-quantitative RT-PCR. As in
embryos, FGF signaling was required for the expression
of sox2 and foxd5a in neuralized mid-gastrula or neur-
ula explants (Figure 3E). Although, zicr1 and soxD
expression were reduced by Δ4a in noggin-injected stage
10.5 embryos (Figure 3A, data not shown), their expres-
sion was greatly reduced or inhibited by Δ4a expression
Figure 2 BMP inhibition and FGF signaling prematurely induce the expression of early neural genes. (A-C) WISH for zicr1, foxd5a and
sox2 of embryos injected with mRNA coding for Nog, FGF8a or Nog + FGF8a and lacZ mRNA (cyan) and collected at stage 8 (t = 6 hpf) and
each subsequent hour after until stage 10.5 (t = 10 hpf) when cultured at room temperature. Red arrows indicate earliest onset of expression. All
images are animal pole view with dorsal to the top. (D) RT-PCR of whole embryos dissected from uninjected embryos (UI) or embryos injected
with Nog, FGF8a or Nog+FGF8a. Embryos were collected as in A-C. Genes analysed are indicated on left side, treatment on top, time of
collection below panel. ODC used for loading control. All images are animal pole view with dorsal to the top.
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Page 5 of 13in noggin-injected explants (Figure 3E). In fact, by neur-
ula stage, the expression of all of the early neural genes
was greatly reduced or lost in explants co-injected with
Noggin and Δ4a. XFD inhibited sox2 and foxd5a expres-
sion and by st. 17 also reduced soxD and gem
expression. In summary, the explant RT-PCR data and
WISH embryo data (Figure 3A-D) indicate that soxD,
sox2, zicr1 and foxd5a require FGF signaling for robust
expression at the gastrula stage, whereas sox3 and gem
require FGF signaling for the maintenance of their
Figure 3 FGF signaling is required for the induction of sox2 and foxd5a expression in the neural plate and the maintenance of other
early neural genes. WISH for (A) sox2, (B) zicr1, (C) foxd5a, and (D) sox3 and gem of embryos that were either uninjected (UI) or injected with
Noggin (Nog), dominant negative FGFR4a (Δ4a), or Nog + Δ4a and were collected at stages 10.5 and 11.5 (A-C) or 12.5 (D). All embryos are
dorsal view with anterior to the top. The dashed line separates the domain of gem expression (right) from that inhibited by Δ4a (top left). (E) RT-
PCR of ectodermal explants for genes indicated on the left side of panel. Explants were dissected from embryos that were either uninjected (UI)
or injected with mRNA coding for Nog, Nog + dominant negative FGFR1 (XFD), Nog+Δ4a, or Nog+XFD+Δ4a.
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inhibition.
FGF8a induces neurons in the presence of BMP signaling
and epidermis formation
FGF8a induces neural gene expression in explants (Fig-
ure 1) and expands their expression in embryos (Figure
2), and FGF signaling is required for the expression of
the neural progenitor markers sox2 and foxd5a in the
neural plate (Figure 3) [8,17]. To determine if FGF
induces early neural gene expression by repressing BMP
signaling, we tested the effect of FGF8a on the expres-
sion of BMP, its targets, and epidermis formation. First,
we determined the temporal expression of BMP target
genes prior to and at the onset of neural induction in
embryos (Figure 4A). Embryos were collected as for Fig-
ure 1. Bmp4 expression was detectable by RT-PCR at 7
hpf, and was increased after the onset of zygotic tran-
scription at 8 hpf (Figure 4A). The direct target of
BMP4, vent2 [42], was also expressed robustly at 7 hpf,
and the expression of vent1, a direct Vent2 target [43],
followed at 8 hpf. Msx-1, a BMP target that is eventually
restricted to the neural plate border, was first detected
at 8 hpf and the definitive epidermal marker epi-k was
not expressed in any stages prior to stage 10.5 but is
expressed at stage 17 (24 hpf, Figure 4A).
To determine the effect of FGF signaling on BMP sig-
naling and epidermal development, we injected mRNA
coding for Noggin, FGF8a, or Nog and FGF8a together,
dissected ectodermal explants, cultured them until stage
17 and performed RT-PCR for markers of BMP signal-
ing and epidermal development. In Noggin-expressing
explants, the expression of BMP4 and its targets were
decreased significantly (Figure 4B). In contrast, FGF8a
enhanced the expression of bmp4,B M Pt a r g e tg e n e
expression and epidermal formation (Figure 4B) even
though it also induced neurons and mesoderm in
explants (Figure 1D). In embryos, overexpression of
FGF8a inhibited vent2 expression at 8 hpf, but expres-
sion recovered one hour later (Additional File 1, Fig.
S 1 B ) .W h e nF G F 8 aa n dN o g g i nw e r ei n j e c t e dt o g e t h e r ,
the expression of all markers except vent2 was lost (Fig-
ure 4B).
These data indicate that FGF signaling is required for
the induction of both sox2 and foxd5a and for the
continued expression of sox3 and gem (Figure 3). Addi-
tionally, overexpression of FGF8a in explants leads to
the expression of markers of neural progenitors, neu-
rons and mesoderm and has no overt effect on epider-
mal development in embryos. To determine the fate of
FGF8a- and Nog/FGF8a -injected cells in embryos, we
injected mRNA coding for Noggin, FGF8a, or Noggin
+FGF8a into 1 of 2 cell embryos, cultured the embryos
until neurula stage, and performed WISH for sox3
(neural progenitors), foxd5a (early neural), ngnr-1
(proneural), n-tub (neurons), msx-1(border cells), vent2
(non-neural ectoderm), and epi-k (epidermis). Overex-
pression of Noggin or FGF8a expanded the neural pro-
genitor marker, sox3 (Figure 4C, Nog, n = 20/22;
FGF8a, n = 19/21) and together, dramatically expanded
its expression throughout the entire injected side (n =
20/20). Alone, neither Noggin nor FGF8a affected the
expression of foxd5a (Nog, n = 13/13; FGF8a, n = 6/
9), but together increased foxd5a expression (Figure
4D, n = 11/13). Noggin had no effect on proneural
(ngnr-1, Figure 4E, n = 14/16) or neuronal (n-tub,F i g -
ure 4F, n = 21/21) gene expression whereas FGF8a
(ngnr-1, n = 14/14; n-tub, n = 20/20) and Nog+ FGF8a
(ngnr-1,n=1 4 / 1 4 ;n-tub, n = 20/20) induced ectopic
expression of ngnr-1 and n-tub in lateral and ventral
ectoderm (Figure 4E, F). These data confirm previous
observations that BMP inhibition is sufficient to induce
neural progenitors, but only weakly induces the forma-
tion of neurons [44]. Furthermore, FGF8 only weakly
expands the neural progenitor population but greatly
expands the population of neurons [40]. These data
indicate that after induction of neural tissue by BMP
antagonists, an additional signal is required to cue pro-
genitors to differentiate into neurons. FGF8a effectively
serves as this signal.
Experiments in explants show that FGF8a does not
induce the expression of neural genes by inhibiting
BMP signaling (Figure 4B). To determine if this is the
case in embryos, we injected FGF8a with and without
Noggin and assayed for the expression of non-neural
ectodermal markers. Noggin repressed the expression of
vent2 (Figure 4H, Additional File 1, Fig. S1B, n = 21/21)
and epi-k (Figure 4F, n = 12/12) and reduced but dis-
persed msx-1 expression (Figure 4G, G’,n=1 2 / 1 2 )i n
neurula stage embryos. In contrast, even though FGF8a
induced ectopic neurons in embryos, it did not repress
the expression of non-neural ectodermal or differen-
tiated epidermal markers (Figure 4G-I, vent2, n = 27/29;
msx-1,n=1 4 / 1 4 ;epi-k, n = 14/22). In fact, ectopic n-
tub (Figure 4F) expression overlapped with that of epi-k
and ectopic msx-1 in the superficial ectodermal layer
(Figure 4 G, I and Additional File 4, Fig. S4). With the
addition of Noggin, the ectopic neurons were excluded
from the deep layer and did not overlap with epidermis,
which is repressed by Noggin (Additional File 4, Fig. S4).
In summary, FGF8a expands proneural, neuronal, and
non-neural domains such that msx1, n-tub and epi-k are
expressed in the same cells but segregated from prolifer-
ating progenitors. Noggin represses epidermal develop-
ment to induce neural markers whereas FGF8a does
not, suggesting that BMP antagonism and FGF signaling
do not use the same mechanisms to induce the expres-
sion of neural genes.
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Page 7 of 13Figure 4 FGF signaling induces neuron formation despite the presence of BMP signaling. (A) RT-PCR of embryos collected at the hpf
indicated at the top. Primers are indicated on the left side of the panel. Ef1a was used as a loading control and samples without MMLV RTase
added were used as RT- controls (far right). (B) RT-PCR of stage 17 ectodermal explants dissected from uninjected embryos (UI) or embryos
injected with mRNA coding for Nog, FGF8a, or Nog+ FGF8a. WE is whole embryo control. Primers for markers of the neural plate border (slug,
msx-1), epidermis (bmp4, vent2, vent1, epi-k) and mesoderm (xbra) and are shown on the left side of the panel. (C-I) WISH for (C) sox3, (D) foxd5a,
(E) ngnr-1, (F) n-tub, (G, G’) msx-1, (H) vent2 and (H) epi-k using embryos that were either uninjected (UI) or injected with either Nog, FGF8a or
Nog+ FGF8a and lacZ mRNA. All stage 17 embryos are a dorsal view with anterior to the top (C-G, I) and G’ embryos are a lateral view of
embryos in G with anterior to the left. Embryos in H are stage 10.5 animal pole view with dorsal to the top. Asterisk indicates expansion in the
deep layer of the ectoderm; white arrow indicates expansion in both the deep and superficial ectoderm and red arrow indicates expansion in
the superficial layer only.
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The long-standing debate over the signals required for
neural induction led us to investigate the requirements
for the induction and maintenance of expression of the
first five genes expressed in the neural plate, which we
designate as early neural genes. We have determined that
BMP inhibition is necessary but not sufficient for the
onset of expression of all of the early neural genes. BMP
inhibition is both necessary and sufficient to induce the
expression of zicr1, but expression of sox2 and foxd5a in
the neural plate also requires signaling through FGFR4a.
Additionally, FGF8a signaling is sufficient to prematurely
induce or expand expression of zicr1, foxd5a and sox2 in
unspecified ectoderm, and to expand the neural tube and
induce ectopic neurons at later stages. However, FGF8a
has no effect on epidermal development indicating that it
does not exert its effect via BMP inhibition. Our results
add to the prior known roles of FGF signaling and BMP
inhibition in neural gene expression by showing that they
are involved in the expression of different early neural
genes, and that they act independently of each other.
BMP signaling is sufficient to inhibit neural gene
expression at the onset of neural induction
Many studies have shown that inhibition of BMP signal-
ing by antagonists such as Chordin [45], Noggin [46]
and Follistatin [47] induces neural tissue. Additionally,
studies have shown that overexpression of known BMP
targets such as Msx-1 [48,49], Xvent1 [50] and Xvent2
[51] ventralize Xenopus embryos. Although BMP signal-
ing is known to repress neural development and induce
epidermal genes [52], studies have yet to show if BMP
signaling inhibits the onset of expression of neural spe-
cification genes (early neural genes) in dorsal ectoderm
or if the induction of their expression is dependent on
other signals. We overexpressed a constitutively active
BMP receptor (CaBMPR) and showed that active BMP
signaling repressed the onset of zygotic expression of
sox2, zicr1, sox3, gem, and foxd5a.C a B M P Ra l s o
repressed the expression of the neural inducer, soxD,b y
the end of gastrulation (Additional File 3, Fig. S3). Since
sox3 and gem are expressed pan-ectodermally until stage
11.5, and thus initially overlap with bmp4 and vent2
expression, it is surprising that CaBMPR repressed their
expression. Why aren’t they repressed by BMP signaling
in ventral cells in early gastrulae? One possibility is that
repression requires both Vent1 and Vent2, which are
not expressed together until mid-gastrula stages unless
prematurely activated by overexpression of CaBMPR.
Overexpression of FGF and BMP antagonists induce zicr1
and foxd5a expression prematurely
Prior experiments led to the conclusion that BMP
antagonism is not sufficient for the induction of neural
tissue in chick epiblast or ventral ectoderm of frogs
[16,18]. We argue that BMP inhibition is sufficient for
the induction of some early neural genes in unspecified
ectoderm. Through our analysis of early neural gene
expression, we find that the initiation of sox2 and
foxd5a expression requires FGF signaling in addition to
inhibition of BMP signalling. This supports the conclu-
sions of previous studies that demonstrated that an
FGF4 morpholino inhibited the expression of sox2 in
ectoderm in response to the dominant negative R-Smad,
Smad5-sbn [17], but contradicts recent studies that
demonstrated that FGF is only required for expression
of sox2 in the circumblastoporal region [8]. However,
we also show that Noggin is sufficient to induce the
expression of foxd5a prematurely in unspecified ecto-
derm indicating that FGF is present in the ectoderm at
this time (Figure 2A, B). This is in contrast to studies
in: (1) chick embryos in which inhibition of BMP signal-
ing is not sufficient to induce the expression of sox2 in
non-neural tissue even in the presence of FGF8 [18]
and; (2) frog embryos in which BMP inhibition by over-
expression of Smad6 was insufficient to induce sox2 in
ventral ectoderm unless TGF-b signaling was also inhib-
ited [15,16] or eFGF added [15]. We argue that differ-
ences in developmental timing, tissue competence and
experimental approaches may account for the different
conclusions drawn. Specifically, our experiments differ
from past studies in that we assay for the expression of
neural genes prior to and contemporaneous with neural
ectoderm specification whereas previous studies tested
the ability of BMP inhibition to convert the fate of epi-
blast or epidermal cells permanently by testing gene
expression in later stage embryos. In past studies, it is
possible that BMP inhibition allowed for transient
expression of neural genes at the onset of neural induc-
tion, but this expression was not maintained and there-
fore not detected. Our studies considered with these
studies indicate that inhibition of BMP induces neural
genes in unspecified ectoderm of early gastrula embryos
but this induction is transient and a second signal such
as a TGFb inhibition [16] or FGF signaling [15] found
only in dorsal ectoderm is required to maintain their
expression.
FGF signaling is required for the induction of sox2 and
foxd5a expression in the neural plate
FGF8a signaling is sufficient to expand sox3 expression
and induce ectopic neurons in embryos (Figure 1 and
Additional File 4, Figure S4). Furthermore, FGF signal-
ing is required for the expression of sox2 and foxd5a.
These two genes are reported to be essential for the dif-
ferentiation of neural ectoderm [53,54] indicating that
FGF signaling is also essential for neural development.
T h el o s so fe x p r e s s i o no ft h e s eg e n e si sn o tr e s c u e db y
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FGF signaling is instructive or permissive and does not
induce sox2 or foxd5a expression by inhibiting BMP sig-
naling. However, the requirements for FGF are different
for other early neural genes. For example, although mis-
expression of dominant negative FGFR4a reduces zicr1
expression at st. 10.5, this loss is rescued by Noggin.
Therefore, FGF signaling induces zicr1 expression by
either inhibiting BMP signaling [28], or sensitizing the
ectoderm to BMP inhibition. The latter hypothesis is
supported by our in vivo experiments (Additional File 4,
Figure S4), which show that subsequent to FGF8a over-
expression, the ectoderm is competent to express both
neural and epidermal markers in the same tissue. Con-
trary to this theory, recent studies in mouse embryonic
stem cells suggest that unlike mFGF2, which promotes
stem-like renewal of multipotent epiblast cells, mFGF8
creates a population of specified transient neural pro-
genitors [55]. However, in these studies the neural pro-
genitors were unable to differentiate into neurons as do
FGF8
+ Xenopus ectodermal cells (Additional File 4, Fig-
ure S4) suggesting that xFGF8a has additional functions
in development [55].
Sox3 and gem are unaffected by knock down of FGF
signaling via Δ4a at early gastrula stages, but their
expression is lost by the end of gastrulation indicating
that although these genes do not require FGF signaling
for induction, FGF is necessary for maintenance of their
expression (Figure 3D). This is supported by the loss of
their expression in stage 17 but not stage 11.5 explants
in response to Δ4a. Furthermore, Sox3 directly activates
the expression of gem [56], and Sox3 and Geminin may
both activate expression of themselves forgoing the
necessity for an instructive signal such as FGF.
Finally, soxD expression has different regulatory
requirements than all of the other early neural genes.
Although it is induced by FGF8a overexpression in
explants (Figure 1D), knock down of FGF signaling via
Δ4a has no effect on soxD expression in embryos (data
not shown) and past studies showed that knock down of
FGF13 signaling also had no effect [57]. Furthermore,
soxD is induced by BMP inhibition (Figure 1D) [37], but
constitutive BMP signaling has no effect on the induc-
tion of soxD at stage 10.5, only on its maintenance at
stage 12 (Additional File 3, Fig. S3).
FGF8a induces and expands neural genes in the presence
of mesoderm without inhibiting BMP signaling and
epidermal development
BMP inhibition by misexpression of Noggin predomi-
nantly induces neural progenitors at the expense of
epidermis (Figure 1D, 4B). In contrast, FGF8a overex-
pression induces the formation of neurons (Figure 1A)
without inhibiting epidermal formation (Figure 4 and
Additional File 4, Fig. S4), suggesting that FGF8a acts
in a pathway independent of BMP inhibition to induce
neural gene expression and neuron formation. How-
ever, induction of mesoderm by FGF8a is dependent
on BMP signaling as it is blocked with the co-injection
of noggin mRNA.
FGF8a signaling induces the premature expression of
neural genes in ectoderm and ectodermal explants in cells
that are also expressing epidermal genes (Figure 4 and
Additional File 4, Figure S4). Although previous studies
showed that the superficial layer of the ectoderm is less
competent to respond to neuronal inducing signals [58],
we found that FGF8a induces n-tub positive neurons in
both the superficial and deep ectodermal layers that over-
lap with epi-k expressing cells (Additional File 4, Figure
S4). One interpretation is that FGF8a maintains the com-
petency of the superficial layer to undergo neurogenesis. It
is also possible that FGF8a induces neurons without
increasing the progenitor pool, but this is hard to envision
without a loss of epidermal gene expression. Another pos-
sibility is that FGF8a overexpression induces mosaic cell
fates in explants based on the levels of protein bound by
each cell. Our data support the hypothesis that overex-
pression of FGF8a maintains cellular competence since
the FGF8 injected cells form many tissue types indicated
by markers of epidermis, neurons and neural progenitors.
Conclusions
In toto, this research shows that FGF signaling induces
two early neural genes, sox2 and foxd5a, independent of
epidermal development. These data refute prior studies
because they show that both BMP inhibition and FGF
signaling are sufficient to induce neural tissue as marked
by early neural genes in Xenopus ectoderm. Finally, we
have shown that the regulation of early neural genes is
unique even within gene families (e.g. soxB1) and there-
fore, conclusions about the requirement for FGF signal-
ing in neural induction may be gene specific. Although
previous models for neural induction stated that either
BMP inhibition was sufficient or FGF signaling was
required for neural induction, here we show that in
Xenopus, there is no neural induction regulatory module
that can explain the induction of all early neural genes;
sox2 and foxd5a require FGF signaling for expression
but sox3, geminin and zicr1 do not.
Methods
Embryo culturing and manipulations
Xenopus laevis embryos were obtained using standard
methods [59] and staged according to Nieuwkoop and
Faber (1994). Animal ectodermal explants were isolated
from stage 8-9 embryos, cultured in 0.75 × Normal
Amphibian Medium (NAM), and were collected
between stages 11.5 and 17 based on sibling embryos.
Rogers et al. BMC Developmental Biology 2011, 11:74
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Synthetic capped mRNA was made by in vitro transcrip-
tion using mMessage mMachine kits (Ambion). For
explant and gain of function assays, 25 pg noggin mRNA
[60,61], 0.5ng of tBR [62] mRNA and 0.3 ng of lacZ or
0.3 ng GFP mRNA was injected into the animal pole of
a 1 or 2-cell embryo with or without 0.5 ng of dominant
negative Xfgfr1 mRNA (XFD) [63], 0.5-1.5 ng of domi-
nant negative XFGFR4a mRNA (Δ4a) [25], or 0.2 ng of
FGF8a mRNA. Embryos were cultured until stages 8-17
and analyzed by WISH or reverse transcription- poly-
merase chain reaction (RT-PCR).
RT-PCR
Semi quantitative RT-PCR was performed as described
[64] with some modifications. Prior to reverse transcrip-
tion, 1 μlo fi s o l a t e dR N Aw a su s e df o rP C Rw i t hp r i -
mers for ef1a (XMMR) to determine if there was DNA
contamination. To make cDNA, 10 μlo fi s o l a t e dR N A
was mixed with 1 μl random hexamers and heated to
65° for five minutes then incubated at 42° with MMLV
for 1 hour. RT minus samples underwent the same
treatment minus MMLV reverse transcriptase. Primers
used: sox2, sox3, geminin, zicr1, soxD, foxd5a, vent2,
vent1, msx1, bmp4, epi-k, nog, fgf8, xbra.R N Aw a s
extracted from a minimum of two whole embryos or 10
explants per stage/treatment.
WISH and b-galactosidase assay
Whole mount in situ hybridization (WISH) was per-
formed as described [65,66] and with the following modi-
fications: embryos were not treated with proteinase K,
triethanolamine, or acetic anhydride, and pre-hybridiza-
tion was shortened to one hour. After an overnight hybri-
dization, embryos were washed in 1× maleic acid buffer
(MAB) and then incubated in digoxigenin antibody at
room temperature for four hours followed by three times
15 minute washed with 1× MAB, and an overnight incu-
bation at 4° in 1× MAB. Finally, embryos were either
fixed in 4% formaldehyde with 0.5% acetic acid, and 2×
SSC, or Bouin’s fixative. For lineage tracing, b-galactosi-
dase activity was visualized with X-gal (Research Organ-
ics). We generated digoxigenin labeled mRNA probes for
sox2 [36], sox3 [67], vent1 [50], vent2 [51,68-70], geminin
[39], or GFP [71], zicr1 [36], soxD [37], foxd5a [35], msx-
1 [72], n-tub [73], and epi-keratin [74].
Additional material
Additional file 1: Fig. S1. FGF8a does not induce Xbra expression
and transiently inhibits vent2 expression. (A) WISH for xbra using
embryos that were uninjected (UI) or injected with mRNA coding for
FGF8a or Nog+ FGF8a with lacZ (cyan) as a tracer and collected at stage
8 and every hour after until stage 10. Embryos were cultured at room
temperature. There is no ectopic induction of Xbra expression in the
injected cells at any stage. (B) WISH for vent2 using embryos that were
uninjected (UI) or injected with mRNA coding for Nog, FGF8a or Nog+
FGF8a with lacZ (cyan) as a tracer and collected at stage 8 (6 hpf) and
every hour after until stage 10.5 (10 hpf). Embryos were cultured at room
temperature. At 8 hpf vent2 expression is decreased in FGF8a injected
embryos but expression rebounded by 9 hpf.
Additional file 2: Fig. S2. BMP inhibition and FGF signaling induce
the expression of early neural genes. (A-B) WISH for zicr1 and sox2 of
embryos injected with mRNA coding for tBR, FGF8a or tBR + FGF8a and
lacZ mRNA (cyan) and collected at stage 8 (t = 6 hpf) and each
subsequent hour after until stage 10.5 (t = 10 hpf) when cultured at
room temperature. (C) RT-PCR of ectodermal explants dissected from
uninjected embryos (UI) or embryos injected with tBR, FGF8a or tBR
+FGF8a. Genes analysed are indicated on left side, treatment on top,
time of collection below panel. ODC used for loading control. All images
are animal pole view with dorsal to the top.
Additional file 3: Fig. S3. CaBMPR is sufficient to repress the
expression of early neural genes in gastrulae. (A-F) WISH of embryos
stages 10.5 (A-E) or 12 (F) for genes as indicated next to each panel.
Embryos were either uninjected (UI) or injected with constitutively active
BMP receptor Alk3 (CaBMPR) and lacZ mRNA. Arrowhead points to site of
injection. Pictures shown are representative of majority phenotype: sox2
(st. 10.5, n = 35/56; st. 12.5, n = 22/30), zicr1 (st. 10.5, n = 27/27; st. 12.5,
n = 26/26), soxD (st. 10.5, n = 18/19; st. 12.5, n = 27/27), sox3 (st. 10.5, n
= 62/70; st. 12.5, n = 39/58), geminin (st. 10.5, n = 14/16; st. 12.5, n = 22/
26), and , foxd5a (st. 10.5, n = 25/30; st. 12.5, n = 14/20).
Additional file 4: Fig. S4. FGF8a induces n-tub positive neurons in
the same tissue layer as epi-k positive epidermis. Bisections of stage
17 whole embryos show that Nog expands sox3 expression in the deep
layer (marked by asterisk) and represses epidermal gene expression n-tub
expression. FGF8a overexpression can expand n-tub expression in both
the deep and superficial layer where epidermal genes (epi-k) are
expressed (white arrow). Nog+ FGF8a only expands sox3 and n-tub in
the superficial layer.
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